← Open Payments lookup

JANENE LEVY-STILL: Open Payments

NPI 1124423090 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$917 in 23 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $339 · 2025 $917

Food & beverage: $917
CompanyPaymentsAmount
Indivior Inc.11$365
ABBVIE INC.3$192
Alkermes, Inc.4$185
Vanda Pharmaceuticals Inc.2$107
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$26
Gilead Sciences, Inc.1$26
Otsuka America Pharmaceutical, Inc.1$17

Products named: SUBLOCADE, VRAYLAR, LYBALVI, FANAPT, ARISTADA, CAPLYTA, REXULTI, HETLIOZ.

Industry payments across MD — which companies pay providers there.